AU2949192A - Arylethanolamine derivatives and their use as beta-3-adrenoceptor agonists - Google Patents

Arylethanolamine derivatives and their use as beta-3-adrenoceptor agonists

Info

Publication number
AU2949192A
AU2949192A AU29491/92A AU2949192A AU2949192A AU 2949192 A AU2949192 A AU 2949192A AU 29491/92 A AU29491/92 A AU 29491/92A AU 2949192 A AU2949192 A AU 2949192A AU 2949192 A AU2949192 A AU 2949192A
Authority
AU
Australia
Prior art keywords
beta
adrenoceptor agonists
arylethanolamine derivatives
arylethanolamine
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU29491/92A
Inventor
Lee James Beeley
Barrie Christian Charles Cantello
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
SmithKline Beecham Ltd
Original Assignee
SmithKline Beecham Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SmithKline Beecham Ltd filed Critical SmithKline Beecham Ltd
Publication of AU2949192A publication Critical patent/AU2949192A/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C217/00—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton
    • C07C217/54—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton
    • C07C217/56—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms
    • C07C217/60—Compounds containing amino and etherified hydroxy groups bound to the same carbon skeleton having etherified hydroxy groups bound to carbon atoms of at least one six-membered aromatic ring and amino groups bound to acyclic carbon atoms or to carbon atoms of rings other than six-membered aromatic rings of the same carbon skeleton with amino groups linked to the six-membered aromatic ring, or to the condensed ring system containing that ring, by carbon chains not further substituted by singly-bound oxygen atoms linked by carbon chains having two carbon atoms between the amino groups and the six-membered aromatic ring or the condensed ring system containing that ring

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
AU29491/92A 1991-11-19 1992-11-19 Arylethanolamine derivatives and their use as beta-3-adrenoceptor agonists Abandoned AU2949192A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB9124512 1991-11-19
GB919124512A GB9124512D0 (en) 1991-11-19 1991-11-19 Novel compounds

Publications (1)

Publication Number Publication Date
AU2949192A true AU2949192A (en) 1993-06-15

Family

ID=10704842

Family Applications (1)

Application Number Title Priority Date Filing Date
AU29491/92A Abandoned AU2949192A (en) 1991-11-19 1992-11-19 Arylethanolamine derivatives and their use as beta-3-adrenoceptor agonists

Country Status (8)

Country Link
AU (1) AU2949192A (en)
GB (1) GB9124512D0 (en)
MX (1) MX9206614A (en)
NZ (1) NZ245157A (en)
PT (1) PT101066A (en)
TW (1) TW222619B (en)
WO (1) WO1993010074A1 (en)
ZA (1) ZA928859B (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5776983A (en) * 1993-12-21 1998-07-07 Bristol-Myers Squibb Company Catecholamine surrogates useful as β3 agonists
US5561142A (en) * 1994-04-26 1996-10-01 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
US5541197A (en) * 1994-04-26 1996-07-30 Merck & Co., Inc. Substituted sulfonamides as selective β3 agonists for the treatment of diabetes and obesity
TW200740779A (en) 2005-07-22 2007-11-01 Mitsubishi Pharma Corp Intermediate compound for synthesizing pharmaceutical agent and production method thereof
ITMI20061581A1 (en) 2006-08-04 2008-02-05 Univ Bari LIGANDS OF THE ADRENERGIC BETA-3 RECEPTOR AND THEIR USE IN THERAPY

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3061334D1 (en) * 1979-06-16 1983-01-20 Beecham Group Plc Ethanamine derivatives, their preparation and use in pharmaceutical compositions
DE3368258D1 (en) * 1982-07-16 1987-01-22 Beecham Group Plc 2-aminoethyl ether derivatives, processes for their preparation and pharmaceutical compositions containing them
GB8310556D0 (en) * 1983-04-19 1983-05-25 Beecham Group Plc Compounds
CA2010638A1 (en) * 1989-03-07 1990-09-07 Leo Alig Bisphenethanolamines

Also Published As

Publication number Publication date
MX9206614A (en) 1994-02-28
GB9124512D0 (en) 1992-01-08
TW222619B (en) 1994-04-21
NZ245157A (en) 1995-03-28
ZA928859B (en) 1994-05-05
PT101066A (en) 1994-02-28
WO1993010074A1 (en) 1993-05-27

Similar Documents

Publication Publication Date Title
AU1959992A (en) 3-aryl-4-hydroxy-3-dihydrofuranone and 3-aryl-4-hydroxy- 3-dihydrothiophenone derivatives
EP0516349A3 (en) 2-hydroxy-2-phenylethylamine derivatives as beta-3-adrenoceptor agonists
AU626396B2 (en) Composition and use
AU1081292A (en) New beta-amino- alpha-hydroxycarboxylic acids and their use
AU652928B2 (en) Lipid-selective antioxidants and their preparation and use
AU5784994A (en) Formulation for use in smokers
HK1014669A1 (en) Use of tetrahydrocarbazole derivatives as 5ht1-receptor agonists
AU1371992A (en) Substituted diphenylethylenes and analogues or derivatives thereof
AU1655192A (en) Antivizal dibenzothiazepinone derivatives
AU2654692A (en) Pyrrolobenzoxazine derivatives as 5-ht agonists and antagonists
AU3502789A (en) Composition and use
AU6571594A (en) Thioindole pyperidinyl derivatives used as antalgics
AU1714792A (en) Glass composition and use
AU1033992A (en) 3-quinuclidine derivatives
AU7186994A (en) Phenyrrole derivatives and their use as dopamine d3 antagonists
AU2949192A (en) Arylethanolamine derivatives and their use as beta-3-adrenoceptor agonists
AU2041792A (en) Pyrazole derivatives, compositions and use
AU1106392A (en) Composition and use
AU647559B2 (en) Pyrimidinyl- and triazinyl-salicylamides and their use and preparation
AU3003592A (en) Transparent part and use thereof
AU5677390A (en) Flame-retardant composition and use
AU1965192A (en) Color-developing compositions and their use
AU2686592A (en) Tetraphenylporphyn derivatives
AU7499091A (en) 9-chlor-prostaglandin-beta -cyclodextrin clathrates and their use as drugs
AU1880792A (en) Benzothiazepinones and their use as anticonvulsants